SynAct Pharma’s Capital Markets Day in Stockholm on May 5, 2023.
SynAct Pharma held a Capital Markets Day in Stockholm on May 5, 2023. The event was well attended and around 60 investors, analysts and journalists participated on site, while another 300 attended the live broadcast. A recorded version of the presentations is available below.
Agenda
| Program | ||
| 13:00 | Introduction | CEO Jeppe Øvlesen |
| Corporate update | Chairman Torbjørn Bjerke | |
| 13:15 | Melanocortin receptors and inflammation resolution | Professor Mauro Perretti |
| SynAct pre-clinical MC peptides | CSO Thomas Jonassen | |
| Q&A Session (break after QA session) | ||
| 14:30 | Unmet needs in RA around DMARD therapies | Dr. Alan Kivitz |
| AP1189 program updates | CSO Thomas Jonassen | |
| AP1189 and MC peptides: Opportunities in RA and beyond | CBO Jim Knight | |
| Q&A Session | ||
| Wrap-up – SynAct on the move | Chairman Torbjørn Bjerke | |
| 16:00 | Reception |